Emyria Ltd Market Cap ($22.26 Million)
Market Cap & Net Worth: Emyria Ltd (EMD)
Emyria Ltd market cap. Emyria Ltd (AU:EMD) has a market capitalization of $22.26 Million (AU$31.46 Million) as of November 1, 2026. Listed on the AU stock exchange, this Australia-based company holds position #24636 globally and #998 in its home market, demonstrating a -11.36% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Emyria Ltd's stock price AU$0.04 by its total outstanding shares 806556529 (806.56 Million). Also see EMD cash flow metrics for how efficiently the company converts equity into cash flow.
Emyria Ltd Market Cap History (2020–2026)
Emyria Ltd market cap history from 2020 to 2026. Data shows change from $52.50 Million to $22.26 Million (-17.76% CAGR). Check current stock price of Emyria Ltd for real-time trading data and today's change.
Emyria Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Emyria Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Emyria Ltd annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
24.14x
Emyria Ltd's market cap is 24.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $52.50 Million | $1.01 Million | -$5.24 Million | 51.81x | N/A |
| 2021 | $219.72 Million | $1.98 Million | -$4.91 Million | 111.20x | N/A |
| 2022 | $97.02 Million | $1.82 Million | -$7.33 Million | 53.24x | N/A |
| 2023 | $29.68 Million | $1.59 Million | -$5.13 Million | 18.64x | N/A |
| 2024 | $19.40 Million | $2.20 Million | -$11.46 Million | 8.81x | N/A |
| 2025 | $33.67 Million | $1.39 Million | -$3.14 Million | 24.14x | N/A |
Competitor Companies of EMD by Market Capitalization
Companies near Emyria Ltd in the global market cap rankings as of November 1, 2026. Also see balance sheet size of Emyria Ltd for a full breakdown of the balance sheet.
Key companies related to Emyria Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #719 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1627 globally with a market cap of $14.50 Billion USD ( AU$20.50 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2005 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2067 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #719 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $312.96 |
| #1627 | Pro Medicus Ltd | AU:PME | $14.50 Billion | AU$196.20 |
| #2005 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $72.22 |
| #2067 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.89 |
Market Capitalization of Emyria Ltd (2020–2026)
Market capitalization of Emyria Ltd from 2020 to today. Between 2020 and today, Emyria Ltd's market cap moved from $52.50 Million to $ 22.26 Million, with a yearly change of -17.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$22.26 Million | -33.90% |
| 2025 | AU$33.67 Million | +73.53% |
| 2024 | AU$19.40 Million | -34.62% |
| 2023 | AU$29.68 Million | -69.41% |
| 2022 | AU$97.02 Million | -55.84% |
| 2021 | AU$219.72 Million | +318.48% |
| 2020 | AU$52.50 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Emyria Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $22.26 Million USD |
| MoneyControl | $22.26 Million USD |
| MarketWatch | $22.26 Million USD |
| marketcap.company | $22.26 Million USD |
| Reuters | $22.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Emyria Ltd
Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services, Clinical Services, and corporate segments. It provides therapy programs for post-traumatic stress disorder (PTSD) and treatment-resistant depression. The company also develops ultra-pure CBD capsules (EMD-RX7, and EMD-… Read more